Bibliography
Export 150 results:
Filters: Keyword is Time Factors [Clear All Filters]
Primary adenocarcinoma in a donor lung: evaluation and surgical management. J Heart Lung Transplant. 2003;22(10):1174-7.
De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Follow-up of a pair of renal transplant recipients from a donor with a malignant lymphoma. Nephrol Dial Transplant. 2002;17(12):2255-7.
Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy. Transplant Proc. 2002;34(5):1784-5.
Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy. Am J Transplant. 2002;2(10):983-8.
Incidental diagnosis of gastric cancer in transplant recipients improves patient survival. Surgery. 2002;132(4):754-8; - discussion - 758-60.
Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery. 2002;50(3):510-6; - discussion - 516-7.
Prolonged in vitro hemolysis of EDTA-anticoagulated blood after a delayed hemolytic transfusion reaction. Transfusion//Transfusion. 2002;42(8):1086-8.
Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7(3):375-81.
Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc. 2001;33(40762):3660-1.
Long-term followup of fresh femoral osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res. 2001;(391 Suppl):S318-27.
Screening human donor corneas during organ culture for the presence of guttae. Br J Ophthalmol. 2001;85(3):272-6.
Development of renal cell carcinoma in living donor kidney grafts. Transplantation. 2000;70(11):1650-6.
Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol. 2000;63(1):46-53.
First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation. 2000;70(12):1747-51.
IgA myeloma of donor origin arising 7 years after allogeneic renal transplant. Br J Haematol. 2000;108(3):592-4.
Technique for repair of lymphocele after liver transplantation using patent blue dye. Transplant Proc. 2000;32(7):2221-2.
A case of ABO-incompatible renal transplant patient with non-insulin-dependent diabetes mellitus; long-standing observation of serial glomerular change by protocol biopsy. Clin Transplant. 1999;13 Suppl 1:43-7.
Determinants of waiting time for heart transplants in the United States. J Heart Lung Transplant. 1999;18(5):414-9.
Long-term follow-up of ABO-incompatible renal transplant recipients. Transplant Proc. 1999;31(40575):256-7.
Severe delayed hemolytic transfusion reaction secondary to anti-At(a). Transfusion. 1999;39(8):834-7.
Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens. 1998;52(5):435-43.
Hemolysis associated with transplantation. Transfusion. 1998;38(3):224-8.
Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplantation proceedings//Transplant Proc. 1998;30(4):1324-6.